We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
–
Cap. Flow
+$173M
Cap. Flow %
97.37%
Top 10 Hldgs %
88.25%
Holding
144
New
144
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$55.4M
2
VMBS icon
Vanguard Mortgage-Backed Securities ETF
VMBS
+$54.4M
3
AMH icon
American Homes 4 Rent
AMH
+$16.5M
4
INVH icon
Invitation Homes
INVH
+$14.6M
5
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$7.24M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Real Estate 19.4%
2 Healthcare 5.2%
3 Technology 2.57%
4 Industrials 1.85%
5 Financials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMVT icon
126
Immunovant
IMVT
$8.27B
$16K 0.01%
+650
New +$13.9K
TBF icon
127
ProShares Short 20+ Year Treasury ETF
TBF
$88.6M
$15K 0.01%
+1,000
New +$15.5K
ZTS icon
128
Zoetis
ZTS
$32.1B
$14K 0.01%
+100
New +$13.1K
GBT
129
DELISTED
Global Blood Therapeutics, Inc.
GBT
$14K 0.01%
+225
New +$15.4K
UNH icon
130
UnitedHealth
UNH
$387B
$13K 0.01%
+45
New +$12.9K
WBA
131
DELISTED
Walgreens Boots Alliance
WBA
$13K 0.01%
+300
New +$12.7K
CI icon
132
Cigna
CI
$74.5B
$12K 0.01%
+65
New +$12.3K
DCPH
133
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$12K 0.01%
+200
New +$10.7K
ARGX icon
134
argenx
ARGX
$53.8B
$11K 0.01%
+50
New +$8.88K
RCKT icon
135
Rocket Pharmaceuticals
RCKT
$376M
$10K 0.01%
+500
New +$9.02K
BLUE
136
DELISTED
bluebird bio
BLUE
$9K 0.01%
+12
New +$9.05K
ELV icon
137
Elevance Health
ELV
$80.9B
$9K 0.01%
+35
New +$9.34K
GSK icon
138
GSK
GSK
$104B
$8K ﹤0.01%
+160
New +$8.21K
INSM icon
139
Insmed
INSM
$23.5B
$8K ﹤0.01%
+300
New +$7.11K
PFE icon
140
Pfizer
PFE
$143B
$7K ﹤0.01%
+211
New +$7.17K
TRIL
141
DELISTED
Trillium Therapeutics Inc.
TRIL
$4K ﹤0.01%
+500
New +$3.09K
DVAX
142
DELISTED
Dynavax Technologies
DVAX
$3K ﹤0.01%
+300
New +$1.52K
SNDX icon
143
Syndax Pharmaceuticals
SNDX
$2.02B
$3K ﹤0.01%
+200
New +$3.05K
VRTX icon
144
Vertex Pharmaceuticals
VRTX
$123B
$3K ﹤0.01%
+10
New +$2.71K
2 3 4 5
6

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q2 2020 Portfolio in Review

Q2 2020 is the first quarter with a 13F filing on record for AlphaCentric Advisors, which disclosed 144 positions worth $177M. Its ten largest holdings account for 88% of the portfolio.

Its largest position is iShares MBS ETF: 500,000 shares worth $55.4M.

By sector, the portfolio is most concentrated in Real Estate at 19% of assets, followed by Healthcare and Technology.

  • AlphaCentric Advisors's largest Q2 2020 buy was iShares MBS ETF: 500,000 shares worth $55.4M.
  • AlphaCentric Advisors's ten largest holdings make up 88% of its $177M portfolio in Q2 2020.
  • AlphaCentric Advisors disclosed 144 positions in Q2 2020, its first 13F filing on record.

Based on AlphaCentric Advisors's 13F filing for Q2 2020, filed 11 Mar 2022.